Alex Sirois

Alex Sirois

InvestorPlace Contributor

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Coupang Stock Seems Doomed To Stay Range-Bound for the Forseeable Future

By Alex Sirois, InvestorPlace Contributor

If CPNG Stock is to become the next Amazon, now is when it sets the stage to do so. International aspirations are just taking flight.

7 Most Promising Penny Stocks to Achieve Your Multibagger Dreams

By Alex Sirois, InvestorPlace Contributor

Penny stocks are a great entry into the market. Here are seven that have the potential to provide quick returns with their strong catalysts.

SOS Stock is Many Things, But Not Investment Grade

By Alex Sirois, InvestorPlace Contributor

SOS stock should not interest investors at this point. For those on the fence, the lack of information and clarity alone should be enough.

Editas Stock Isn’t Worth Buying This Early Into Treatment Development

By Alex Sirois, InvestorPlace Contributor

EDIT stock is part of a pioneering movement in CRISPR gene editing, but there's no way to know whether the company will succeed long term.

Churchill Capital Stock Is Likely to Rally in the Short-Term, Sink in the Longer Term

By Alex Sirois, InvestorPlace Contributor

CCIV stock will move a lot in the next few months. The owners of the stock should pay close attention to these dates.

Load More